The EU's drug regulator has given the green light to Pfizer's Covid-19 antiviral pill Paxlovid to be used on adults at risk of serious illness.
Member states can now deploy the drug with a number of countries that have already bought Paxlovid, including Germany and Italy.
Plaxovid is currently being developed at Pfizer's Irish plants in Ringaskiddy and Newbridge.